Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed the efficacy of tofacitinib using pooled data from two phase 3 studies of patients with active PsA. METHODS: Data were pooled from OPAL Broaden (NCT01877668) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nash, Peter, Coates, Laura C., Fleischmann, Roy, Papp, Kim A., Gomez-Reino, Juan Jesus, Kanik, Keith S., Wang, Cunshan, Wu, Joseph, Menon, Sujatha, Hendrikx, Thijs, Ports, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251851/
https://www.ncbi.nlm.nih.gov/pubmed/30414064
http://dx.doi.org/10.1007/s40744-018-0131-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251851/
https://www.ncbi.nlm.nih.gov/pubmed/30414064
http://dx.doi.org/10.1007/s40744-018-0131-5

Ejemplares similares